GSK Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BN7SWP63
GBP
18.57
1.6 (9.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
7,629.00
8,618.00
8,547.00
7,986.00
7,516.00
8,117.00
8,012.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,629.00
8,618.00
8,547.00
7,986.00
7,516.00
8,117.00
8,012.00
Raw Material Cost
1,873.00
2,639.00
2,239.00
2,165.00
1,926.00
2,537.00
2,328.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
167.00
188.00
167.00
184.00
162.00
173.00
156.00
Selling and Distribution Expenses
2,085.00
2,674.00
2,162.00
2,132.00
2,054.00
2,627.00
3,767.00
Other Expenses
135.10
215.20
140.80
179.10
123.50
166.30
128.50
Total Expenditure (Excl Depreciation)
5,476.00
7,653.00
5,976.00
6,272.00
5,377.00
7,000.00
7,536.00
Operating Profit (PBDIT) excl Other Income
2153
965
2571
1714
2139
1117
476
Other Income
372.00
462.00
258.00
416.00
223.00
305.00
223.00
Operating Profit (PBDIT)
2,988.00
2,220.00
3,567.00
3,289.00
3,185.00
2,268.00
1,650.00
Interest
167.00
188.00
167.00
184.00
162.00
173.00
156.00
Exceptional Items
-210.00
-284.00
-210.00
-57.00
-92.00
-686.00
-478.00
Gross Profit (PBDT)
5,756.00
5,979.00
6,308.00
5,821.00
5,590.00
5,580.00
5,684.00
Depreciation
463.00
793.00
738.00
1,159.00
823.00
846.00
951.00
Profit Before Tax
2,148.00
951.00
2,452.00
1,889.00
2,108.00
563.00
65.00
Tax
305.00
223.00
312.00
241.00
336.00
62.00
-1.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,737.00
636.00
2,013.00
1,443.00
1,624.00
414.00
-58.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,737.00
636.00
2,013.00
1,443.00
1,624.00
414.00
-58.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
102.00
91.00
131.00
203.00
148.00
87.00
123.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,839.00
727.00
2,144.00
1,646.00
1,772.00
501.00
65.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.31
0.31
0.31
0.31
0.31
0.31
0.31
Reserves
17,852.00
16,377.00
16,148.00
14,791.00
14,157.00
13,671.00
14,008.00
Earnings per share (EPS)
0.43
0.16
0.49
0.35
0.39
0.1
-0.01
Diluted Earnings per share
0.43
0.16
0.49
0.35
0.39
0.1
-0.01
Operating Profit Margin (Excl OI)
28.22%
11.2%
30.08%
21.46%
28.46%
13.76%
5.94%
Gross Profit Margin
34.22%
20.24%
37.32%
38.17%
39.0%
17.36%
12.68%
PAT Margin
22.77%
7.38%
23.55%
18.07%
21.61%
5.1%
-0.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.48% vs 0.83% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 152.96% vs -66.09% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 48.81% vs -46.87% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -11.17% vs 12.57% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of GSK Plc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Net Sales
7,629.00
11,346.40
-3,717.40
-32.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,629.00
11,346.40
-3,717.40
-32.76%
Raw Material Cost
1,873.00
2,712.66
-839.66
-30.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
167.00
291.68
-124.68
-42.75%
Selling and Distribution Expenses
2,085.00
3,008.78
-923.78
-30.70%
Other Expenses
135.10
227.77
-92.67
-40.69%
Total Expenditure (Excl Depreciation)
5,476.00
8,290.85
-2,814.85
-33.95%
Operating Profit (PBDIT) excl Other Income
2,153.00
3,055.54
-902.54
-29.54%
Other Income
372.00
194.45
177.55
91.31%
Operating Profit (PBDIT)
2,988.00
4,263.80
-1,275.80
-29.92%
Interest
167.00
291.68
-124.68
-42.75%
Exceptional Items
-210.00
-44.53
-165.47
-371.59%
Gross Profit (PBDT)
5,756.00
8,633.74
-2,877.74
-33.33%
Depreciation
463.00
1,013.81
-550.81
-54.33%
Profit Before Tax
2,148.00
2,913.79
-765.79
-26.28%
Tax
305.00
618.23
-313.23
-50.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,737.00
2,285.90
-548.90
-24.01%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,737.00
2,285.90
-548.90
-24.01%
Share in Profit of Associates
0
0
0.00
Minority Interest
102.00
0.74
101.26
13,683.78%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,839.00
2,286.65
-447.65
-19.58%
Equity Capital
0
0
0.00
Face Value
0.31
0.19
0.00
Reserves
17,852.00
35,893.68
-18,041.68
-50.26%
Earnings per share (EPS)
0.43
1.46
-1.03
-70.55%
Diluted Earnings per share
0.43
1.46
-1.03
-70.55%
Operating Profit Margin (Excl OI)
28.22%
26.93%
0.00
1.29%
Gross Profit Margin
34.22%
34.62%
0.00
-0.40%
PAT Margin
22.77%
20.15%
0.00
2.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 762.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.48% vs 0.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.50% vs 2.08% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 183.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 152.96% vs -66.09% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.78% vs 63.92% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 261.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 48.81% vs -46.87% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -11.68% vs 16.98% in Mar 2025

Quarterly - Interest
Interest 16.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.17% vs 12.57% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.09% vs -2.41% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.22%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025